Edmonton, Canada

Pavel Robertovich Badalov

USPTO Granted Patents = 4 

Average Co-Inventor Count = 10.1

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2022-2023

Loading Chart...
4 patents (USPTO):

Title: Pavel Robertovich Badalov: Innovator in Nucleoside Preparation

Introduction

Pavel Robertovich Badalov, an accomplished inventor based in Edmonton, Canada, has made significant contributions to the field of medicinal chemistry. With four patents to his name, Pavel has focused on developing innovative methods and compounds that hold promise in various pharmaceutical applications.

Latest Patents

Among his latest patents, Pavel has developed methods for preparing 1'-cyano nucleosides. This patent outlines the processing of these compounds, specifically detailing the preparation from a compound of Formula (II-a) in a flow reactor. His work in this area is instrumental in enhancing the efficiency of nucleoside synthesis. Additionally, he has created solid forms of a toll-like receptor modulator, which includes crystalline forms, solvates, and hydrates of a specific compound, (R)-2-((2-amino-7-fluoropyrido[3,2-d]pyrimidin-4-yl)amino)-2-methylhexan-1-ol, along with methods for their preparation.

Career Highlights

Pavel currently works for Gilead Sciences, Inc., a prominent biopharmaceutical company renowned for its innovative advancements in medicine. His career at Gilead has been marked by a commitment to developing breakthroughs in therapeutic solutions, especially in the areas of viral infections and oncology. Pavel's work has not only contributed to expanding the company's patent portfolio but also to advancing the field of pharmaceutical research.

Collaborations

Throughout his career, Pavel has collaborated with talented colleagues, including Tiago Vieira and Detian Gao. These partnerships have fostered a collaborative environment that encourages the sharing of ideas and the pursuit of innovative solutions to complex problems in the field of biomedicine.

Conclusion

Pavel Robertovich Badalov exemplifies the spirit of innovation in the pharmaceutical industry. His pioneering work on nucleosides and toll-like receptor modulators showcases his dedication to improving healthcare outcomes through scientific research. As he continues to refine his methods and collaborate with fellow innovators, Pavel is sure to make enduring contributions to the world of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…